These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 32241019)
1. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis. Lu Y; Jiang J; Ren C PLoS One; 2020; 15(4):e0230979. PubMed ID: 32241019 [TBL] [Abstract][Full Text] [Related]
2. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer. Shao N; Cai Q Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis. Wang J; Zhou X; Liu Y; Li Z; Li X PLoS One; 2017; 12(4):e0176008. PubMed ID: 28441396 [TBL] [Abstract][Full Text] [Related]
4. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC). Mirili C; Guney IB; Paydas S; Seydaoglu G; Kapukaya TK; Ogul A; Gokcay S; Buyuksimsek M; Yetisir AE; Karaalioglu B; Tohumcuoglu M Int J Clin Oncol; 2019 Feb; 24(2):168-178. PubMed ID: 30109543 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of neutrophil to lymphocyte ratio and clinicopathological characteristics for multiple myeloma: A meta-analysis. Zeng Q; Liu Z; Li Q; Liu T Medicine (Baltimore); 2018 Oct; 97(41):e12678. PubMed ID: 30313061 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer. Suzuki R; Lin SH; Wei X; Allen PK; Welsh JW; Byers LA; Komaki R Radiother Oncol; 2018 Mar; 126(3):499-505. PubMed ID: 29398150 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis. Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294 [TBL] [Abstract][Full Text] [Related]
9. Hemoglobin, albumin, lymphocyte, and platelet score and neutrophil-to-lymphocyte ratio are novel significant prognostic factors for patients with small-cell lung cancer undergoing chemotherapy. Yang N; Han X; Yu J; Shu W; Qiu F; Han J J Cancer Res Ther; 2020 Sep; 16(5):1134-1139. PubMed ID: 33004760 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer. Suzuki R; Wei X; Allen PK; Cox JD; Komaki R; Lin SH Clin Lung Cancer; 2019 Mar; 20(2):117-123. PubMed ID: 30611672 [TBL] [Abstract][Full Text] [Related]
11. Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis. Jiang AM; Zheng HR; Liu N; Zhao R; Ma YY; Bai SH; Tian T; Liang X; Ruan ZP; Fu X; Yao Y Cancer Control; 2021; 28():10732748211050581. PubMed ID: 34654345 [TBL] [Abstract][Full Text] [Related]
12. Association of the neutrophil to lymphocyte ratio and clinical outcomes in patients with lung cancer receiving immunotherapy: a meta-analysis. Jin J; Yang L; Liu D; Li W BMJ Open; 2020 Jun; 10(6):e035031. PubMed ID: 32499266 [TBL] [Abstract][Full Text] [Related]
13. Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis. Takenaka Y; Oya R; Kitamiura T; Ashida N; Shimizu K; Takemura K; Yamamoto Y; Uno A Head Neck; 2018 Mar; 40(3):647-655. PubMed ID: 29076207 [TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors. Na N; Yao J; Cheng C; Huang Z; Hong L; Li H; Qiu J Oncotarget; 2016 Jul; 7(28):44039-44046. PubMed ID: 27270655 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-Analysis. Tang H; Li B; Zhang A; Lu W; Xiang C; Dong J PLoS One; 2016; 11(7):e0159447. PubMed ID: 27427969 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer. Wang J; Kalhor N; Hu J; Wang B; Chu H; Zhang B; Guan Y; Wu Y PLoS One; 2016; 11(10):e0163397. PubMed ID: 27695079 [TBL] [Abstract][Full Text] [Related]
17. The Relation between Hemogram Parameters and Survival in Extensive-Stage Small Cell Lung Cancer. Sakin A; Sahin S; Yasar N; Demir C; Arici S; Geredeli C; Cihan S Oncol Res Treat; 2019; 42(10):506-515. PubMed ID: 31336378 [TBL] [Abstract][Full Text] [Related]
18. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis. Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336 [TBL] [Abstract][Full Text] [Related]
19. Clinical value of neutrophil-to-lymphocyte ratio in patients with non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors. Jiang T; Bai Y; Zhou F; Li W; Gao G; Su C; Ren S; Chen X; Zhou C Lung Cancer; 2019 Apr; 130():76-83. PubMed ID: 30885355 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of neutrophil-to-lymphocyte ratio for nasopharyngeal carcinoma: A meta-analysis. Yin J; Qin Y; Luo YK; Feng M; Lang JY Medicine (Baltimore); 2017 Jul; 96(29):e7577. PubMed ID: 28723793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]